The management of heart failure: a FADOI survey in the setting of Internal Medicine Units
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Heart failure (HF) is a chronic disease characterized by high morbidity and mortality. FADOI conducted a survey aimed at obtaining information on the management of HF in Italy, with particular reference to the Internal Medicine (IM) Units. The questionnaire, containing 32 questions, was sent to the Directors. Up to August 2022, it was possible to analyze data from140 centers. In 47.4±17.2% of cases with HF, the patients have preserved systolic function; 41% are in NYHA class III, 33% in class IV (33%), 21% and 5% in NYHA class II and I, respectively. The mean length of hospital stay is 9±2.5 days, with an inhospital mortality of 11.9%±9.5%. After discharge, the re-hospitalizations are 21.3±12.7%. In 44.4% of IM departments, there is a formal diagnostic-therapeutic care pathway. Also, through surveys, it is possible to help hospitals to and optimize assistance to patients affected by HF.
Altmetrics
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.